Be part of stomach & oesophageal cancer research

15th February 2021

Have you, or someone you care for, been given a medication called Lonsurf for treatment of advanced stomach cancer and cancer of the oesophageal (gullet)/stomach junction? Or have you had at least two whole body treatments for advanced cancer and are now being given best supportive care?

Please consider completing this survey, that will help inform future medications.

Trifluridine–tipiracil (Lonsurf) is a cancer medicine (chemotherapy) for the treatment of adult patients with stomach cancer and cancer of the junction between the stomach and gullet. This medication is proposed to be used for people who have been previously treated with at least two whole body treatments for advanced cancer.

This medicine (chemotherapy) is proposed for treatment when most people would only be given best supportive care for their cancer as a third treatment. It is very unusual to receive more than two chemotherapy treatments because of lack of evidence of benefit to patients.

The Scottish Medicines Consortium (SMC) is committed to working in partnership with patient groups to capture patient and carer experiences and use these to inform decision-making with regards to approval of medicines for use in Scotland. They are requesting the opinion of patients and carers of patients with these cancers about the use of this treatment. If you are living in the UK and have tried this treatment; or are living with best supportive care for cancer; or are a carer for someone with these advanced cancers, we would like to hear your views on living with this diagnosis and what the possible benefits and drawbacks are of this treatment.

The deadline for completing this survey is 22nd February 2021.

Click here to complete the survey. You will play your part in informing future medications.

DISCOVER MORE:

  • twitter
  • facebook
  • linkedin
  • youtube
  • tiktok
  • instagram

Read more posts...

World IBD Day 2022

On World Inflammatory Bowel Disease (IBD) Day every year (19th May), patient organisations come together from all over the globe to raise awareness of Crohn’s disease & colitis. What is IBD? Inflammatory Bowel Diseases are...

16th May 2022

World Barrett’s Oesophagus Day 2022

Each year, the 16th May marks World Barrett’s Oesophagus Day. Barrett’s oesophagus affects around 10% of those who suffer with persistent heartburn… but have you heard of it? What is Barrett’s oesophagus? Barrett’s oesophagus is...

15th May 2022

Coeliac Disease Awareness Week 2022

On Coeliac Disease Awareness Week, Guts UK is raising awareness of this condition – in particular the delay to diagnosis. Research has shown that on average, it takes 13 years to get a diagnosis of...

9th May 2022

Liverpool Pancreatic Forum 2022

On the 17th June 2022, the Liverpool Pancreatic Forum will return in-person for the first time since COVID-19. Guts UK were delighted to hear that the Liverpool Pancreatic Forum group were returning for their 7th...

3rd May 2022

Touring toilet cubicle aims to abolish the poo taboo!

Guts UK is delighted to announce that from the 5th to the 8th April, we’ll be visiting Northampton, Liverpool and London… in style! With our friends at Fybogel, we’ll be in touring toilet cubicles (also...

4th April 2022

#GUTSelfie Campaign

On 27th June 2021, Guts UK launched our unique awareness campaign, The #GUTSelfie Campaign. We reached out to people on Instagram who are affected by a range of digestive diseases. We gave our ‘gut army’...

26th June 2021